Yahoo Finance • 3 months ago
Revvity Inc (NYSE:RVTY) showcases robust growth in the health science solutions sector. Strategic acquisitions and innovative product launches position Revvity Inc (NYSE:RVTY) for competitive advantage. Market value of common stock held by... Full story
Yahoo Finance • 4 months ago
Revvity (NYSE:RVTY) Full Year 2023 Results Key Financial Results Revenue: US$2.75b (down 17% from FY 2022). Net income: US$179.5m (down 65% from FY 2022). Profit margin: 6.5% (down from 16% in FY 2022). The decrease in margin was driven... Full story
Yahoo Finance • 6 months ago
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. (“Revvity” or the “Company”) (NYSE: RVTY). Such investors are advised to contact Robert S. Willoughby at newactio... Full story
Yahoo Finance • 6 months ago
Revvity, Inc. (NYSE:RVTY) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Hello, and welcome to the Q3 2023 Revvity Earnings Conference Call. My name is Alex. I’ll be coordinating the call today. [Operator Instructions] I’ll n... Full story
Yahoo Finance • 6 months ago
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. (“Revvity” or the “Company”) (NYSE: RVTY). Such investors are advised to contact Robert S. Willoughby at newaction@... Full story
Yahoo Finance • a year ago
The HIVE CLX Single-Cell RNAseq Solution integrates sample storage and single cell profiling into a robust, instrument-free workflow Studies in innate immunology, infectious diseases and clinical research aided by the HIVE’s capabilities f... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
